Legacy Bridge, LLC has disclosed its latest investment holdings in a recent filing, showcasing a total value of $309,613,458 as of September 30, 2026. This report is significant as it provides insights into the firm’s investment strategy and market positioning.

Legacy Bridge, LLC, incorporated in Delaware, operates within the financial services sector. The company is categorized under various SIC descriptions, although specific details were not provided in the filing. Its recent filings include several 13F-HR forms, with the latest submitted on October 28, 2026, under accession number 0001689144-26-000004.

The filing indicates that Legacy Bridge holds investments in a diverse range of companies. Notable holdings include:

  • AB Active ETFs Inc: $445,115
  • Abbott Laboratories: $276,033
  • Amazon.com Inc: $4,444,089
  • Apple Inc: $2,872,631
  • Alphabet Inc: $3,303,475
  • Advanced Micro Devices Inc: $5,509,511

These investments reflect Legacy Bridge's strategy of diversifying its portfolio across various sectors, including technology, healthcare, and consumer goods. The firm’s total reported holdings consist of 328 different positions, indicating a broad investment approach.

The impact of this filing may resonate across the financial services industry, particularly among competitors who monitor investment trends and strategies. Legacy Bridge's significant investments in leading companies suggest a robust confidence in their growth potential, which could influence market dynamics.

Looking ahead, the filing does not specify what actions Legacy Bridge plans to take next regarding its investments. However, stakeholders and analysts will likely keep a close eye on the company's future filings to gauge any shifts in strategy or new investments.